🍪 The GLP Lounge uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsClinical Trials & ResearchEcnoglutide, mazdutide, and other emerging GLP-1 pipeline agents Page 4

Ecnoglutide, mazdutide, and other emerging GLP-1 pipeline agents

TrialTracker_MD Thu, Jun 4, 2026 at 9:47 AM 19 replies 418 viewsPage 4 of 4
jason_sac26
New Member
34
123
Jan 2026
Sacramento, CA
Jun 6, 2026 at 11:57 AM#16
Dr.NateNeph said:
The mechanism and the magnitude are separate questions.

Can confirm. Same sequence, different timescale.

Last edited: Jun 6, 2026 at 1:57 PM
27 2pete_RVA, CarlaRPh_TPA, steph_laguna and 24 others
Reply Quote Save Share Report
LabKate
Senior Member
2,678
11,234
Jan 2024
Oregon
Jun 6, 2026 at 6:30 PM#17
SleepDoc_PDX said:
If you are going to change something, change one thing and give it long enough to express itself.

Adding the part of the answer the thread has not reached. Most of what circulates confidently in this community traces back to one summary of one study, and the qualifier was dropped somewhere in the third retelling.

26 1laura_annarbor, JenMemphis, pat_auckland and 23 others
Reply Quote Save Share Report
Dr.PathRoch
Member
456
2,123
Jun 2024
Rochester, MN
Jun 7, 2026 at 1:03 AM#18

The figures, for anyone assembling their own picture. The boring version of this is the one that works, and the boring version is: measure a baseline, change one variable, wait, measure again under the same conditions. Nobody wants that answer and it is still the answer.

25 0WendyG_ATL, SaraMom3, Dr.MetabolicMD and 22 others
Reply Quote Save Share Report

Sigma-Aldrich — Research-Grade Standards

Certified reference materials, analytical reagents, and research-grade standards for peptide verification. Trusted by laboratories worldwide.

Shop Reference Standards
BethLabQueen
Senior Member
1,234
5,678
May 2024
Virginia
Online
Jun 7, 2026 at 7:37 AM#19

A narrower follow-up, since the general answer is now clear:

How would you tell the difference between that and the alternative explanation?

Last edited: Jun 7, 2026 at 8:37 AM
24 24cory_ATX, lori_vegas, Dr.PulmRoch and 21 others
Reply Quote Save Share Report
Admin
Administrator
2,456
9,812
Oct 2023
Online
Jun 7, 2026 at 2:11 PM#20

Moderator note: a couple of off-topic posts removed.

2 2PeptideSynthNJ, Dr.KarenChen
Reply Quote Save Share Report

Similar Threads

FLOW trial: semaglutide renal outcomes — NEJM publication review14 replies
SELECT trial: semaglutide 2.4mg cardiovascular outcomes — 4yr data9 replies
TRIUMPH program (retatrutide) — Phase 3 trial design and endpoints13 replies
Orforglipron ATTAIN trials — oral non-peptide GLP-1 agonist8 replies
CagriSema (amylin + semaglutide) — REDEFINE Phase 3 results20 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register